Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy.
Jamy O, Arora S, Meredith R, Salzman D, Di Stasi A, Minagawa K, Mineishi S, Saad A. Jamy O, et al. Among authors: mineishi s. Bone Marrow Transplant. 2022 Oct;57(10):1597-1599. doi: 10.1038/s41409-022-01757-9. Epub 2022 Jul 9. Bone Marrow Transplant. 2022. PMID: 35810256 Clinical Trial. No abstract available.
Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
Saad A, Taneja A, Di Stasi A, Sarmad R, Kukkamalla R, Costa L, Salzman D, Innis-Shelton R, Chewning JH, Meredith RF, Hauptfeld V, Langford S, Plessala K, Bhatia R, Lamb LS, Mineishi S. Saad A, et al. Among authors: mineishi s. Bone Marrow Transplant. 2018 Oct;53(10):1345-1348. doi: 10.1038/s41409-018-0185-6. Epub 2018 May 4. Bone Marrow Transplant. 2018. PMID: 29728698 No abstract available.
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.
Jamy O, Innis-Shelton R, Bal S, Paluri R, Salzman D, Di Stasi A, Costa L, Meredith R, Lamb L, Minagawa K, Mineishi S, Saad A. Jamy O, et al. Among authors: mineishi s. Am J Hematol. 2021 Oct 1;96(10):E396-E398. doi: 10.1002/ajh.26296. Epub 2021 Jul 31. Am J Hematol. 2021. PMID: 34288026 Free article. Clinical Trial. No abstract available.
Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities.
Pizzola CJ, Cioccio J, Rakszawski KL, Nickolich M, Ehmann WC, Rybka WB, Wirk B, Naik S, Zheng H, Silar B, Shike H, Zhou S, Mineishi S, Minagawa K, Claxton DF. Pizzola CJ, et al. Among authors: mineishi s. Bone Marrow Transplant. 2022 Nov;57(11):1743-1745. doi: 10.1038/s41409-022-01821-4. Epub 2022 Sep 12. Bone Marrow Transplant. 2022. PMID: 36097041 No abstract available.
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
Haverkos BM, Abbott D, Hamadani M, Armand P, Flowers ME, Merryman R, Kamdar M, Kanate AS, Saad A, Mehta A, Ganguly S, Fenske TS, Hari P, Lowsky R, Andritsos L, Jagasia M, Bashey A, Brown S, Bachanova V, Stephens D, Mineishi S, Nakamura R, Chen YB, Blazar BR, Gutman J, Devine SM. Haverkos BM, et al. Among authors: mineishi s. Blood. 2017 Jul 13;130(2):221-228. doi: 10.1182/blood-2017-01-761346. Epub 2017 May 3. Blood. 2017. PMID: 28468799 Free PMC article.
159 results